Study Overview
This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.
Description
Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.
Official Title
Pulmonary Hypertension Biorepository and Registry
Quick Facts
Study Start:2020-08-10
Study Completion:2027-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
| Inclusion Criteria | Exclusion Criteria |
|---|
| |
Contacts and Locations
Study Locations (Sites)
University of Kansas Medical Center
Kansas City, Kansas, 66160
United States
Collaborators and Investigators
Sponsor: University of Kansas Medical Center
- Leslie A Spikes, MD, PRINCIPAL_INVESTIGATOR, Assistant Professor of Medicine
- Luigi R Boccardi, MPH, STUDY_DIRECTOR, Director of Pulmonary Research
Study Record Dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
Study Start Date2020-08-10
Study Completion Date2027-07-31
Study Record Updates
Study Start Date2020-08-10
Study Completion Date2027-07-31
Terms related to this study
Additional Relevant MeSH Terms
- Pulmonary Hypertension
- Pulmonary Arterial Hypertension
- Pulmonary Hypertension Due to Left Heart Disease
- Pulmonary Hypertension, Primary
- Pulmonary Hypertension Due to Lung Diseases and Hypoxia
- Pulmonary Hypertension, Primary, 4
- Pulmonary Hypertension, Primary, 2
- Pulmonary Hypertension, Primary, 3
- Chronic Thromboembolic Pulmonary Hypertension